18,120 Shares in Addus HomeCare Corporation $ADUS Bought by Aurora Investment Counsel
Aurora Investment Counsel recently acquired a new stake of 18,120 shares in Addus HomeCare Corporation (NASDAQ:ADUS), valued at approximately $1,821,000. Other institutional investors have also adjusted their holdings in the company, which now has 95.35% institutional ownership. Despite an insider stock sale, Addus HomeCare's stock saw a 1.6% increase, and analysts project an EPS of 6.29 for the current fiscal year, with a "Moderate Buy" rating.
Summit Creek Advisors LLC Acquires Shares of 85,118 Addus HomeCare Corporation $ADUS
Summit Creek Advisors LLC has acquired 85,118 shares of Addus HomeCare Corporation (ADUS), valued at approximately $8.55 million, making it their fifth-largest holding. Institutional investors own 95.35% of Addus HomeCare, with other major holders including BlackRock and Vanguard. The company recently reported strong quarterly earnings, exceeding analyst estimates, and maintains a "Moderate Buy" consensus rating from analysts with an average price target of $130.88.
TimesSquare Capital Management LLC Buys Shares of 313,549 Addus HomeCare Corporation $ADUS
TimesSquare Capital Management LLC has acquired 313,549 shares of Addus HomeCare Corporation (NASDAQ:ADUS) worth approximately $31.5 million, representing 1.68% of the company. Institutional investors now own 95.35% of ADUS, which holds a "Moderate Buy" rating from analysts with an average price target of $130.88. The company recently surpassed quarterly earnings expectations with $1.73 EPS and $377.41 million in revenue, an 8% increase year-over-year.
Rice Hall James & Associates LLC Takes $4.29 Million Position in Addus HomeCare Corporation $ADUS
Rice Hall James & Associates LLC has acquired a new stake of 42,704 shares, valued at approximately $4.29 million, in Addus HomeCare Corporation (NASDAQ:ADUS). Other institutional investors also increased their holdings, contributing to institutional ownership of 95.35% for the company. Analysts maintain a "Moderate Buy" rating with an average price target of $130.88, following the company's Q2 earnings which surpassed expectations with $1.73 EPS and $377.41 million in revenue.
Addus HomeCare (NASDAQ: ADUS) COO details equity stake
Addus HomeCare Corp's COO, W. Bradley Bickham, filed a Form 3 disclosing his initial equity stake in the company. He reported direct ownership of 34,678 shares of Common Stock as of August 7, 2026. The filing is an initial statement of beneficial ownership, not indicating a recent purchase or sale, and also references a Power of Attorney for filing-related actions.
Bank of America Corp DE Grows Stock Holdings in Addus HomeCare Corporation $ADUS
Bank of America Corp DE increased its stake in Addus HomeCare Corporation (NASDAQ:ADUS) by 11.3% in the first quarter, now owning 323,037 shares valued at approximately $30.3 million. Addus HomeCare recently reported strong quarterly earnings, beating analyst estimates with $1.73 EPS and an 8.0% year-over-year revenue increase. The company maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $130.88.
Is Addus HomeCare’s Leadership Shake-Up And Earnings Beat Reframing the Investment Case For Addus (ADUS)?
Addus HomeCare (ADUS) recently announced a leadership change, with President and COO Heather Dixon departing and former President and COO Brad Bickham returning as interim COO, alongside reporting stronger Q2 2026 earnings. This shake-up, coupled with improved profitability and a focus on larger acquisitions, is influencing the company's investment narrative. While the company aims for significant revenue and earnings growth by 2029, investors should consider potential risks like rising labor costs and heavy reliance on Medicaid.
Why Did Addus HomeCare (ADUS) Move Today?
Addus HomeCare (ADUS) saw its stock price climb following the departure of its President and COO, Heather Dixon, and the return of Brad Bickham as interim COO. Despite this leadership change and recent Q2 results, analysts believe ADUS is undervalued, citing expected state-level reimbursement rate increases. However, potential Medicare reimbursement cuts and workforce shortages pose risks to future growth and margins.
Brad Bickham Returns as Addus HomeCare Interim COO
Addus HomeCare Corporation announced that Heather Dixon, president and chief operating officer, has left the company. Brad Bickham, former president and chief operating officer, will return as interim COO for one year, effective immediately. CEO Dirk Allison expressed gratitude for Dixon's contributions and confidence in Bickham's ability to ensure a seamless transition due to his extensive experience with the company.
Addus HomeCare Appoints W. Bradley Bickham as Interim COO Following Heather Dixon's Exit
Addus HomeCare Corporation announced the departure of President and COO Heather Dixon, effective August 7, 2026. W. Bradley Bickham has been appointed as interim Chief Operating Officer, also effective August 7, 2026. Bickham, who previously served as President and COO, will have an annual base salary of $622,000 and his employment agreement extends through July 31, 2027.
Addus HomeCare (ADUS) COO Heather Dixon exits as veteran leader Brad Bickham returns
Addus HomeCare Corporation announced that President and COO Heather Dixon left the company on August 7, 2026. Veteran leader W. Bradley Bickham, who previously served as President and COO, has been appointed as interim Chief Operating Officer. Bickham's employment agreement will run through July 31, 2027, with an annualized base salary of $622,000.
Wasatch Advisors LP Has $68.41 Million Stake in Addus HomeCare Corporation $ADUS
Wasatch Advisors LP has reduced its stake in Addus HomeCare Corporation (NASDAQ:ADUS) by 21.5% during the second quarter, selling 186,899 shares, but still holds 680,926 shares valued at $68.41 million. Addus HomeCare reported strong quarterly earnings, beating analyst estimates with $1.73 EPS and an 8% revenue increase year-over-year. Analysts maintain a "Moderate Buy" rating with an average price target of $130.88, while institutional investors own 95.35% of the stock.
Addus HomeCare COO departs, former executive returns interim By Investing.com
Addus HomeCare Corporation (NASDAQ:ADUS) announced the departure of its President and Chief Operating Officer, Heather Dixon. Brad Bickham, a former President and COO, will return on an interim basis for one year. CEO Dirk Allison thanked Dixon for her contributions, while highlighting Bickham's past role in expanding the company's services and acquisition strategy.
Addus appoints Bickham to role of interim COO following departure of Dixon
Addus HomeCare announced that President and COO Heather Dixon has departed the company, with former President and COO Brad Bickham returning as interim COO for a year. The announcement follows Addus's strong second-quarter earnings, where profits rose by 24.9% and revenues grew by 8%. CEO Dirk Allison praised Bickham's deep operational knowledge and thanked Dixon for her contributions.
Addus COO Departs; CenterWell Names New President Of Home Solutions
Heather Dixon, COO of Addus HomeCare, has left the company, with Brad Bickham stepping in as interim COO. Concurrently, CenterWell appointed Casey McKeon as president of home solutions to lead Humana’s home care strategy. The article also details several other significant leadership changes and appointments across various home care and health service companies, including HarmonyCares, National Alliance for Care at Home, Always Best Care, and Maxim Healthcare.
Addus HomeCare Names Brad Bickham Interim COO Following Heather Dixon’s Departure
Addus HomeCare Corporation (Nasdaq: ADUS) has appointed Brad Bickham as interim Chief Operating Officer following the departure of Heather Dixon. Bickham, previously the company's President and COO, will serve for one year to ensure operational continuity during the leadership transition. CEO Dirk Allison thanked Dixon for her contributions and expressed confidence in Bickham's ability to oversee the company's extensive home care operations and growth strategy.
Addus HomeCare COO departs, former executive returns interim
Addus HomeCare Corporation announced the departure of Heather Dixon, President and Chief Operating Officer. Brad Bickham, a former President and COO, will return on an interim basis for one year. CEO Dirk Allison expressed gratitude for Dixon's contributions, while highlighting Bickham's previous role in the company's expansion and acquisition strategy in hospice and home health services.
Addus HomeCare Corporation (NASDAQ:ADUS) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Addus HomeCare Corporation recently released its Q2 results, prompting analysts to update their financial forecasts for the current fiscal year. The company's stock has seen a significant increase in price target from analysts, reflecting optimism about its future performance. Key changes in analyst expectations and the impact of these revisions on the company's valuation are detailed.
Addus HomeCare Corporation $ADUS Position Decreased by Empowered Funds LLC
Empowered Funds LLC significantly reduced its stake in Addus HomeCare Corporation (ADUS) by 62.3% in Q1 2026, selling over 44,000 shares. Despite this, institutional investors still own a substantial 95.35% of the company, and analysts maintain a "Moderate Buy" consensus with an average price target of $130.88. Addus HomeCare reported strong Q1 earnings, surpassing EPS estimates and showing an 8% year-over-year revenue increase.
Addus on the Hunt for M&A Deals
Addus Homecare is actively seeking mergers and acquisitions in home care and skilled home health to expand its market reach and increase geographic density. The company, which closed one personal care acquisition and has another in the works, reported strong financial performance in the first half of 2026, with significant increases in net service revenues and adjusted EBITDA. Addus also indicated it is open to home health transactions and is focused on maintaining a balanced patient mix in its hospice segment despite some payment cap liability.
Addus HomeCare Q2 Momentum Seen Continuing, RBC Says
RBC Capital Markets believes Addus HomeCare (ADUS) will continue its strong Q2 momentum into the second half of 2026, driven by improved staffing, acquisition benefits, and higher reimbursement rates. The firm expects ADUS to achieve double-digit organic growth and views it as a top pick among its home health coverage, reiterating an Outperform rating.
RBC Capital Adjusts Price Target on Addus HomeCare to $134 From $130, Maintains Outperform Rating
RBC Capital has increased its price target for Addus HomeCare (NASDAQ:ADUS) to $134 from $130, while reiterating an Outperform rating on the stock. This adjustment suggests a positive outlook on the company's financial performance or market position. Investors should note this change in analyst sentiment.
Addus revenues jump 8%, as personal care and hospice expansion offset home health decline
Addus HomeCare reported an 8% year-over-year revenue increase in Q2 2026, reaching $377.4 million, driven by strong performance in its personal care and hospice divisions. CEO Dirk Allison announced plans for continued growth through mergers and acquisitions, particularly in personal care and home health care, fueled by cash reserves and optimism from a proposed CMS rate increase for 2027. Despite a decline in home health revenue, the company anticipates a strong finish to 2026 with a projected 12% to 13% increase.
Addus HomeCare Corp 2Q 2026: Revenue $377.42M, EPS $1.49— 10-Q Summary
Addus HomeCare Corp reported its second-quarter 2026 results, showing significant growth in revenue and diluted EPS. The company's revenue increased by 8% to $377.42 million, and diluted EPS rose by 24.2% to $1.49, primarily driven by organic personal care growth and strategic acquisitions. Addus HomeCare expanded its personal care footprint through five acquisitions, while also noting an increased managed care mix and mixed clinical trends with strong hospice growth but declining home health volumes.
Addus HomeCare Eyes More M&A As HomeCourt Deal Exceeds Expectations
Addus HomeCare Corporation's recent acquisition of HomeCourt Home Care has surpassed expectations, primarily due to higher client volume. This success, along with strong Q2 financial performance, is fueling Addus's strategy for further acquisitions and expansion into new markets. The company is also implementing a technology transition to a single EMR platform to enhance its "bridge program," which connects personal care with home health and hospice services.
Earnings call transcript: Addus HomeCare beats Q2 2026 estimates, shares fall 5.4%
Addus HomeCare reported higher-than-expected Q2 2026 earnings and revenue, with adjusted EPS of $1.73 and revenue of $377.4 million, beating analyst estimates. Despite the beat, the company's shares fell by 5.4% due to the narrow margin of the beat and mixed segment trends. Management expressed optimism for the second half of 2026, anticipating improved personal care census growth and home health performance, and is actively pursuing M&A opportunities while maintaining a strong balance sheet.
Addus HomeCare (ADUS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Addus HomeCare (ADUS) reported strong Q2 2026 earnings, with revenue up 8% year-over-year to $377.42 million, beating the Zacks Consensus Estimate. EPS also surpassed expectations at $1.73. The company saw significant growth in personal care revenue, though home health and hospice segments experienced smaller changes compared to estimates.
Addus HomeCare Q2 revenue rises 8% to $377.4 million
Addus HomeCare reported an 8% increase in Q2 2026 net service revenues, reaching $377.4 million, with net income rising to $27.6 million. The company's adjusted EBITDA grew by 11.9% year-over-year, and it held $99.6 million in cash as of June 30, 2026. Insider trading shows significant sales activity, while institutional investors had mixed movements in their holdings.
Earnings Flash (ADUS) Addus HomeCare Corporation Posts Q2 Adjusted EPS $1.73 per Share, vs. FactSet Est of $1.70
Addus HomeCare Corporation (ADUS) reported its Q2 adjusted EPS of $1.73 per share, surpassing the FactSet estimate of $1.70. The company's personal care segment was highlighted by UBS as a key driver for exceeding expectations. This earnings flash was published on August 3, 2026.
Earnings Flash (ADUS) Addus HomeCare Corporation Reports Q2 Revenue $377.4M, vs. FactSet Est of $376.2M
Addus HomeCare Corporation announced its second-quarter 2026 revenue reached $377.4 million, surpassing the FactSet estimate of $376.2 million. The company's adjusted EPS for the quarter was $1.73 per share, also beating the FactSet estimate of $1.70 per share. This financial performance indicates stronger-than-expected results for the home care services provider.
Addus earnings up next: Can M&A fuel growth amid sector headwinds?
Addus HomeCare Corporation is expected to report its second-quarter results today, with analysts projecting steady growth despite regulatory pressures in the home care industry. The company is anticipated to deliver earnings of $1.69 per share on revenue of $376.26 million, representing significant year-over-year increases. Investors will be closely watching the company's acquisition strategy and the performance of its personal care segment, which is a major revenue driver, as well as updates on its home health segment's return to growth.
Addus HomeCare (ADUS) Q2 Earnings Report Preview: What To Look For
Addus HomeCare (ADUS) is scheduled to report its Q2 earnings this Monday. The company missed revenue expectations last quarter, but analysts anticipate a 7.7% year-on-year revenue growth for the upcoming report. Peers in the senior health sector, BrightSpring Health Services and Chemed, have already reported positive Q2 results, potentially indicating a favorable outlook for ADUS.
ADUS|Addus Homecare Corp|Price:115.670|Chg%:+1.120
Addus Homecare Corp (ADUS) shows healthy fundamentals and high growth potential, with its valuation considered fairly valued. Institutional ownership is high, and analysts have predominantly rated it as a Buy with a target price of $133.00, suggesting an upward trend in the medium term despite technical indicators not fully supporting the current trend.
Addus Homecare Corp (ADUS) Cash Flow
This article provides a detailed cash flow statement for Addus Homecare Corp (ADUS), broken down into operating, investing, and financing activities. It presents quarterly and annual financial data, allowing users to evaluate the company's financial health and stability. The article also includes a FAQ section defining different types of cash flow and their significance for ADUS.
Addus Homecare Corp (ADUS) Balance Sheet
This article provides detailed quarterly and annual balance sheet data for Addus Homecare Corp (ADUS), allowing users to assess the company's financial health, analyze fundamentals, and calculate key ratios. It includes information on assets, liabilities, and shareholders' equity, along with FAQs explaining important balance sheet metrics and how to interpret them.
Addus HomeCare Corporation Revenue Breakdown – NASDAQ:ADUS
Addus HomeCare Corporation (NASDAQ: ADUS) generated $1.42 billion USD in revenue last year. The Personal Care segment was the top-performing segment, contributing $1.09 billion USD. All of the company's revenue came from the United States.
ADUS|Addus Homecare Corp|Price:114.550|Chg%:+2.630
Addus Homecare Corp (ADUS) stock increased by 2.35%, reaching $114.550. The company provides home care services across three segments: Personal Care, Hospice, and Home Health. Key executives and major shareholders are listed, with institutional holdings totaling approximately $19.38 million.
Is Addus HomeCare (ADUS) Trading At A Discount On Reimbursement Growth Hopes?
Addus HomeCare (ADUS) has drawn investor attention due to its recent stock performance and appears undervalued at $111.92 against a narrative fair value of $132.69. The company's valuation is influenced by its home-based care model, acquisition record, and expected state-level reimbursement rate increases. Investors are advised to consider potential Medicare payment cuts and reliance on government reimbursement when evaluating ADUS.
Citizens reiterates Addus HomeCare stock rating on service synergies
Citizens has reiterated a Market Outperform rating and a $142.00 price target for Addus HomeCare (NASDAQ:ADUS), citing the company's strong personal care footprint and potential for service synergies. The firm expects Addus HomeCare's robust balance sheet to facilitate M&A opportunities. Despite a recent revenue miss in Q1 2026 earnings, which led to a slight price target adjustment from $150, Citizens maintains its positive outlook due to the stock trading at a valuation discount within its historical EBITDA range.
Addus HomeCare Corporation (A41) Q3 2024 Earnings Report - Results, Call & Slides
Addus HomeCare Corporation (A41) has released its Q3 2024 earnings report, showing a beat on both EPS and revenue expectations. The company reported actual EPS of €1.14 against a consensus of €1.13, and actual revenue of €254.52M compared to an expected €254.24M, marking a 7.04% year-over-year revenue growth. The next earnings report is estimated for August 3, 2026.
Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring A 19% Upside Potential
Addus HomeCare Corporation (ADUS) shows a promising 19.28% upside potential with strong financial metrics, including a market capitalization of $2.08 billion, robust revenue growth of 7.70%, and over $102 million in free cash flow. Analysts are overwhelmingly positive, with 12 out of 14 rating it a "buy," and technical indicators suggest bullish momentum. The company's diversified service segments and strategic reinvestment of profits position it as a compelling opportunity for growth-oriented investors in the healthcare sector.
Addus HomeCare sets Q2FY26 earnings release date
Addus HomeCare Corporation announced it will release its financial results for the second quarter ended June 30, 2026, on August 3, 2026, after market close. A conference call featuring senior leadership, including CEO Dirk Allison and CFO Brian Poff, is scheduled for August 4, 2026, at 9:00 a.m. Eastern Time. The company currently provides home care services to over 62,000 patients across 24 states.
Addus HomeCare publishes update to financial calendar
Addus HomeCare has announced an update to its financial calendar. The company is set to release its Q2 2026 earnings on August 3, 2026, after the market closes. Management will further discuss these results on an earnings conference call scheduled for 9:00 a.m. ET on August 4, 2026, which will also be webcast.
Addus HomeCare (ADUS) Investor presentation Summary
Addus HomeCare (ADUS) operates in 23 states, providing personal care, hospice, and home health services, primarily to the elderly, chronically ill, and disabled. The company demonstrated strong financial performance in 2025 with $1.4 billion in revenues and $180 million adjusted EBITDA, driven by organic growth and strategic acquisitions, including Gentiva's personal care operations. Addus focuses on cost-effective, long-term care and maintains a strong balance sheet to support its expansion and value-based care opportunities.
Addus HomeCare’s Broad Russell Index Removal Might Change The Case For Investing In ADUS
Addus HomeCare Corporation (NasdaqGS: ADUS) was removed from several Russell Growth indices in late June 2026, including the Russell 2000, 2500, 3000, 3000E, and Small Cap Growth benchmarks. This removal could impact the demand from index-tracking funds and active managers, potentially reshaping liquidity and the company's shareholder base. While the core investment narrative around long-term demand for home care and managing reimbursement/labor pressures remains, the index change introduces new considerations for investors regarding policy risks and potential shifts in investor demand.
Addus HomeCare (ADUS) AGM 2026 Summary
This article summarizes the Addus HomeCare (ADUS) 2026 Annual General Meeting (AGM) held virtually on June 10, 2026. Key agenda items included the election of two Class 2 directors, Michael Earley and Veronica Hill-Milbourne, for three-year terms, auditor ratification, and executive compensation approval. The meeting achieved a quorum, and only company-nominated directors were considered.
Addus HomeCare (ADUS) Q1 2025 earnings summary
Addus HomeCare (ADUS) reported strong Q1 2025 earnings, with net service revenues increasing 20.3% to $337.7 million and adjusted EBITDA up 25.1% to $40.6 million. The growth was primarily driven by organic expansion, acquisitions like Gentiva, and strength in the personal care segment. The company also improved its gross margin, reduced bank debt, and provided a positive outlook for full-year adjusted EBITDA margin and continued organic growth.
ADUS: Moratorium And Index Removals Will Present A Long-Term Opportunity
Analysts have lowered their price targets and fair value for Addus HomeCare (ADUS) due to a higher discount rate, a more conservative revenue growth outlook, and regulatory actions. The new Medicare home health and hospice moratorium, while presenting near-term growth challenges, is seen by some as a potential long-term opportunity, allowing the company to focus on internal execution and integration. Additionally, Addus HomeCare was dropped from several Russell growth benchmarks.
ADUS - Addus HomeCare Corp Options
This article provides a detailed financial overview of Addus HomeCare Corp (ADUS), including its last closing price, market capitalization, income, sales, and various financial ratios. It also lists performance metrics such as EPS growth, sales growth, insider/institutional ownership, profitability, and stock performance over different periods.
Precision Trading with Addus Homecare Corporation (ADUS) Risk Zones
This article provides an in-depth analysis of Addus Homecare Corporation (ADUS) with a focus on risk zones and trading strategies based on AI models. It highlights the stock's strong near and mid-term sentiment, weak long-term outlook, and outlines specific position, momentum breakout, and risk-hedging trading strategies with entry zones, targets, and stop losses. The analysis also includes multi-timeframe signal strength, support, and resistance levels for various time horizons.
